Clinical Trial Update: Dual Add-on Therapy in Type 2 Diabetes Poorly Controlled With Metformin Monotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial update for dual add-on therapy in type 2 diabetes inadequately controlled on metformin monotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Diabetes Mellitus, Type II | Phase 3 | Status: UNKNOWN